Cancer
AndroMETa_M24-533
Colorectal Cancer
M24-533: A Phase 2, Open-Label, Randomized, Master Protocol Study to Evaluate Safety and Efficacy of Multiple Treatment Combinations with ABBV-400 in Subjects with Metastatic Colorectal Cancer– Feasibility Request
Contact Research Team:
[email protected]
Site principal investigator:
Marc Roth, MD
Learn more about this study:
NCT06820463